BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3470134)

  • 1. Cytogenetics and cell surface marker analysis in chronic myelocytic leukemia. II. Implications for patient management.
    Fuscaldo KE; Brodsky I; Crilley P; Ligler FS
    Cancer Genet Cytogenet; 1987 May; 26(1):25-37. PubMed ID: 3470134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetics and cell surface marker analysis in CML--1. Prediction of phenotype of acute phase transformation.
    Ligler FS; Brodsky I; Schlam ML; Fuscaldo KE
    Leuk Res; 1985; 9(9):1093-8. PubMed ID: 3865030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetics and flow cytometry may predict phenotype of CML blast crisis.
    Ligler FS; Brodsky I; Schlam ML; Fuscaldo KE
    Cancer Detect Prev; 1985; 8(1-2):317-23. PubMed ID: 3864537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blast crisis of Philadelphia chromosome-positive chronic myelocytic leukemia (CML). Treatment results of 69 patients.
    Anger B; Carbonell F; Braunger I; Heinze B; Gutensohn W; Thiel E; Heimpel H
    Blut; 1988 Sep; 57(3):131-7. PubMed ID: 3166389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL; Wang XN; Liu HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic granulocytic leukemia: correlation of blastic transformation type with karyotypic evolution.
    O'Malley FM; Garson OM
    Am J Hematol; 1985 Dec; 20(4):313-23. PubMed ID: 3865531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.
    Su XY; Wong N; Cao Q; Yu LZ; Niu C; Wickham N; Johnson PJ; Chen Z; Chen SJ
    Cancer Genet Cytogenet; 1999 Jan; 108(1):6-12. PubMed ID: 9973917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential karyotype study on Ph-positive chronic myelocytic leukemia. Significance of additional chromosomal abnormalities during disease evolution.
    Krulik M; Smadja N; de Gramont A; Gonzalez-Canali G; Audebert AA; Dray C; Brissaud P; Debray J
    Cancer; 1987 Sep; 60(5):974-9. PubMed ID: 3475159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
    Kantarjian HM; Keating MJ; Talpaz M; Walters RS; Smith TL; Cork A; McCredie KB; Freireich EJ
    Am J Med; 1987 Sep; 83(3):445-54. PubMed ID: 3477958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The morphological, immunophenotypical and cytogenetic characteristics study of blast crisis in chronic myeloid leukemia].
    Tang X; Wu D; Xue Y; Zhu M; Lu D; Ruan C
    Zhonghua Nei Ke Za Zhi; 2002 Oct; 41(10):685-7. PubMed ID: 12485536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of secondary chromosomal aberrations of chronic myelocytic leukemia.
    Wang Y; Hopwood VL; Hu P; Lennon A; Osterberger J; Glassman A
    Cancer Genet Cytogenet; 2004 Aug; 153(1):53-6. PubMed ID: 15325094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prognostic implications of secondary chromosomal aberrations in Philadelphia chromosome-positive chronic myeloid leukemia patients after imatinib mesylate treatment].
    Zhang Y; Jiang Q; Qiu JY; Chen SS; Jiang B; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):648-50. PubMed ID: 17967235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone marrow transplantation as therapy in chronic myeloid leukemia].
    Schmeiser T; Arnold R; Wiesneth M; Hertenstein B; Bunjes D; Anger B; Heit W; Heimpel H
    Dtsch Med Wochenschr; 1988 Jan; 113(1):6-10. PubMed ID: 3275532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duplication of Ph and of 9q+ chromosomes during the blastic transformation of a CML case.
    Avanzi GC; Giovinazzo B; Saglio G; Guerrasio A; Rosso A; Bertini M; Resegotti L; Pegoraro L
    Cancer Genet Cytogenet; 1987 Nov; 29(1):57-63. PubMed ID: 3478129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute promyelocytic transformation of chronic myeloid leukaemia with an isochromosome 17q.
    van der Merwe T; Bernstein R; Derman D; Stanley A; Dukes I; Murray J; Weaving A
    Br J Haematol; 1986 Dec; 64(4):751-6. PubMed ID: 3467788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karyotype evolution in CML: high frequency of translocations other than the Ph.
    Sessarego M; Panarello C; Coviello DA; Boccaccio P; Ajmar F
    Cancer Genet Cytogenet; 1987 Mar; 25(1):73-80. PubMed ID: 3467834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal culture and cytogenetics. Indicators of a variant of chronic myelogenous leukemia.
    Selvaggi S; Wolman SR; Bornstein S; Edinger F
    Cancer; 1984 Dec; 54(12):2956-8. PubMed ID: 6594190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of clonal evolution in transformed chronic myelogenous leukemia.
    Ruff P; Saragas E; Poulos M; Weaving A
    Cancer Genet Cytogenet; 1995 Jun; 81(2):182-4. PubMed ID: 7621419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blast crisis of chronic myelogenous leukemia. Morphologic and immunological features.
    Nemoto K; Honma K; Fukuda T; Ohnishi Y
    Acta Pathol Jpn; 1986 Oct; 36(10):1441-54. PubMed ID: 3541490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.